Remissions following anti-CD22 CAR therapy in children with relapsed ALL
3 Dec 2016
Remissions following anti-CD22 CAR therapy in children with relapsed ALL
A new spin on leukaemia therapy
Anti CD22 CAR T cell therapy for relapsed paediatric ALL
Editor's Choice for November 2016
Towards delivering truly personalised therapy for oesophageal cancer
Highlights of the SIOG posterwalk
What are the successes of SIOG?
Advancements in the field of geriatric oncology
Clinical research in geriatric oncology
Target mutations in lung cancer
Immunotherapy for the elderly
Closing poll on CDK inhibition in advanced breast cancer with failing antiestrogens